Company Overview of SyStemix, Inc.
SyStemix, Inc. was acquired by Novartis AG. In February 1997, SyStemix, Inc. completed a merger with Novartis Biotech Holding Corp., an indirect wholly owned subsidiary of Novartis, Inc., pursuant to which SyStemix became an indirect wholly owned subsidiary of Novartis. Previously, SyStemix, Inc. was engaged in the development of cellular and cell-based gene therapies for cancer, AIDS, and genetic diseases based on the use of isolated, expanded, and gene-modified hematopoietic stem cells.
3155 Porter Drive
Palo Alto, CA 94304
Key Executives for SyStemix, Inc.
SyStemix, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Benson Hill Biosystems, Inc.||United States|
|Gemstone Biotherapeutics LLC||United States|
|Semma Therapeutics, Inc.||United States|
|Axygen Biosciences, Inc.||United States|
|Archivex, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact SyStemix, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.